Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;33(6):e5036.
doi: 10.1002/pro.5036.

Site-directed mutagenesis reveals the interplay between stability, structure, and enzymatic activity in RidA from Capra hircus

Affiliations

Site-directed mutagenesis reveals the interplay between stability, structure, and enzymatic activity in RidA from Capra hircus

Giulia Rizzi et al. Protein Sci. 2024 Jun.

Abstract

Reactive intermediate deaminase A (RidA) is a highly conserved enzyme that catalyzes the hydrolysis of 2-imino acids to the corresponding 2-keto acids and ammonia. RidA thus prevents the accumulation of such potentially harmful compounds in the cell, as exemplified by its role in the degradation of 2-aminoacrylate, formed during the metabolism of cysteine and serine, catalyzing the conversion of its stable 2-iminopyruvate tautomer into pyruvate. Capra hircus (goat) RidA (ChRidA) was the first mammalian RidA to be isolated and described. It has the typical homotrimeric fold of the Rid superfamily, characterized by remarkably high thermal stability, with three active sites located at the interface between adjacent subunits. ChRidA exhibits a broad substrate specificity with a preference for 2-iminopyruvate and other 2-imino acids derived from amino acids with non-polar non-bulky side chains. Here we report a biophysical and biochemical characterization of eight ChRidA variants obtained by site-directed mutagenesis to gain insight into the role of specific residues in protein stability and catalytic activity. Each mutant was produced in Escherichia coli cells, purified and characterized in terms of quaternary structure, thermal stability and substrate specificity. The results are rationalized in the context of the high-resolution structures obtained by x-ray crystallography.

Keywords: 2‐aminoacrylate; 2‐imino acids; RidA; metabolic damage; protein stability; reactive intermediate deaminase A; x‐ray crystallography.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
(a) Multiple alignment of RidA protein sequences from Salmo salar‐isoform 1 (A0A1S3KNQ3), S. salar‐isoform 2 (C0H8I4), Capra hircus (P80601), Homo sapiens (P52758), Mus musculus (P52760), Oryctolagus cuniculus (G1U8R2), Arabidopsis thaliana (Q94JQ4), and Escherichia coli (P0AF93). Protein sequences were analyzed using Clustal Omega and ESPript3. Fully conserved residues are highlighted in red; partially conserved residues are in red; blue frames indicate sequence stretches with globally high similarity. Blue stars indicate residues that have been mutated. The N‐terminal signal peptide sequence of A. thaliana was omitted from the alignment. (b,c) Ribbon representation of ChRidA homotrimeric structure (PDB ID: 1NQ3) (b) and of a ChRidA monomer with residues mutated in this study shown as spheres (c).
FIGURE 2
FIGURE 2
Summary of the effects of amino acid substitutions on the substrate specificity of the RidA forms. (a) The activity of RidA variants, as measured from the initial velocity of semicarbazone formation in coupled assays containing different L‐amino acids, LAAO, semicarbazide, and varying amounts of RidA forms (vRidA), is expressed as percentage of the initial velocity of semicarbazone formation in the absence of RidA (vo). Symbols and color code are as follows: L‐Leu, red circles; L‐Ala, blue squares; L‐His, magenta stars; L‐Phe, green triangles; L‐Trp, orange inverted triangles; L‐Glu, purple diamonds. Full symbols and empty symbols of different sizes indicate independent experiments. No curves were drawn when the RidA variant had no detectable activity. (b) Catalytic efficiency of each RidA variant (100/K50) with respect to the imino acids derived from six L‐amino acids. The inset panel allows to inspect the low‐activity values exhibited by some of the RidA variants. Only V25W exhibited detectable activity with the imino acid derived from L‐His.
FIGURE 3
FIGURE 3
(a) Ribbon representation of the superposition of wt and mutant ChRidA trimers. Color code: Wt ChRidA, gray; ChRidA‐R107A, red; ChRidA‐R107K, orange; ChRidA‐R107W, yellow; ChRidA‐K78A, blue; ChRidA‐E124A, cyan; ChRidA‐V25W, pink; ChRidA‐A108D, purple; ChRidA‐I126Y, green. (b) Ribbon representation of the superposition of wt and variant ChRidA monomers using the same color code as in (a).
FIGURE 4
FIGURE 4
(a–c) Representation of active site of ChRidA‐R107A (red, a), ChRidA‐R107K (orange, b) and ChRidA‐R107W (yellow, c) in comparison with wt ChRidA. Dotted lines represent the interatomic distances between atoms. (d–f) Representation of the inter‐monomeric interface of wt ChRidA (gray, d), ChRidA‐K78A (blue, e), and ChRidA‐E124A (light blue, f). The salt bridge present in wt ChRidA is represented as dotted line. (g) Comparison of residues orientation of ChRidA‐V25W (pink) and wt ChRidA (gray) in the proximity of V25W mutation. (h) Comparison of residues orientation of ChRidA‐A108D (purple) and wt ChRidA (gray) in the proximity of A108D mutation. Salt bridges are represented as dotted lines. (i) Comparison of residues orientation and central cavity filling of ChRidA‐I126Y (green) and wt ChRidA (gray). In ChRidA‐I126Y the three monomers are represented with different shades of green.

Similar articles

References

    1. Afonine PV, Grosse‐Kunstleve RW, Echols N, Headd JJ, Moriarty NW, Mustyakimov M, et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr D Biol Crystallogr. 2012;68:352–367. - PMC - PubMed
    1. Asagi K, Oka T, Arao K, Suzuki I, Thakur MK, Izumi K, et al. Purification, characterization and differentiation‐dependent expression of a perchloric acid soluble protein from rat kidney. Nephron. 1998;79:80–90. - PubMed
    1. Borchert AJ, Ernst DC, Downs DM. Reactive enamines and imines in vivo: lessons from the RidA paradigm. Trends Biochem Sci. 2019;44:849–860. - PMC - PubMed
    1. Borchert AJ, Walejko JM, Guennec AL, Ernst DC, Edison AS, Downs DM. Integrated metabolomics and transcriptomics suggest the global metabolic response to 2‐aminoacrylate stress in Salmonella enterica . Metabolites. 2019;10:E12. - PMC - PubMed
    1. Burman JD, Stevenson CEM, Sawers RG, Lawson DM. The crystal structure of Escherichia coli TdcF, a member of the highly conserved YjgF/YER057c/UK114 family. BMC Struct Biol. 2007;7:30. - PMC - PubMed